A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells

Experimental Hematology

Volumn 32, Issue 7, 2004, Pages 614-621

  Harada, Hideki ^a,d   Watanabe, Satoru ^a   Saijo, Kaoru ^a   Ishiwata, Isamu ^b   Ohno, Tadao ^a,c  

^a RIKEN   (Japan)

^b Ishiwata Obstet and Gynecol Hosp   (Japan)

^c Cell Medicine Inc   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; INTERLEUKIN 2;

ARTICLE; CELL FRACTIONATION; CELL PROLIFERATION; CELL SELECTION; CYTOTOXICITY; DILUTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; STEM CELL; TUMOR CELL LINE;

ANTIGENS, CD; ANTIGENS, CD56; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOMAGNETIC SEPARATION; K562 CELLS; KIDNEY NEOPLASMS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; WILMS TUMOR;

EID: 3042837951     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.03.011     Document Type: Article

References (34)

1. Lanier L.L., Le A.M., Civin C.I., Loken M.R., Phillips J.H. Relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 136:1986;4480-4486
2. Robertson M.J., Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 76:1990;2421-2438
3. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 22:2001;633-640
4. Domzig W., Stadler B.M., Herberman R.B. Interleukin 2 dependence of human natural killer (NK) cell activity. J Immunol. 130:1983;1970-1973
5. Caligiuri M.A., Zmuidzinas A., Manley T.J., Levine H., Smith K.A., Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med. 171:1990;1509-1526
6. Harada H., Saijo K., Watanabe S., et al. Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT. Jpn J Cancer Res. 93:2002;313-319
7. Oikawa T., Kawai K., Ishiwata I., Ohno T., Akaza H. Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer. BJU Int. 92:2003;1009-1015
8. Kawai K., Sasaki T., Saijou K., et al. Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay. Cancer Immunol Immunother. 35:1992;225-229
9. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. J Immunol. 126:1981;1614-1619
10. Harada H, Saijo K, Ishiwata I, Ohno I. A GFP-transfected HWFT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assay. Human Cell. In Press.
11. + granular lymphocytes with a natural killer-sensitive tumor cell, K562. J Exp Med. 161:1985;1464-1482
12. Ythier A., Delmon L., Reinherz E., et al. Proliferative responses of circulating human NK cells: delineation of a unique pathway involving both direct and helper signals. Eur J Immunol. 15:1985;1209-1215
13. London L., Perussia B., Trinchieri G. Induction of proliferation in vitro of resting human natural killer cells: IL-2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J Immunol. 137:1986;3845-3854
14. Rabinowich H., Sedlmayr P., Herberman R.B., Whiteside T.L. Increased proliferation, lytic activity, and purity of human natural killer cells co-cultured with mitogen-activated feeder cells. Cell Immunol. 135:1991;454-470
15. Robertson M.J., Manley T.J., Donahue C., Levine H., Ritz J. Costimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol. 150:1993;1705-1714
16. + lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL-2)-induced activated killer (AK) cells. J Immunol. 134:1985;802-807
17. - cell population in cord blood and adult peripheral blood. J Immunol. 135:1985;2351-2356
18. Ferrini S., Miescher S., Zocchi M.R., von Fliedner V., Moretta A. Phenotypic and functional characterization of recombinant interleukin 2 (rIL-2)-induced activated killer cells: analysis at the population and clonal levels. J Immunol. 138:1987;1297-1302
19. Voss S.D., Leary T.P., Sondel P.M., Robb R.J. Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor γ chain. Proc Natl Acad Sci USA. 90:1993;2428-2432
20. Phillips J.H., Takeshita T., Sugamura K., Lanier L.L. Activation of natural killer cells via the p75 interleukin 2 receptor. J Exp Med. 170:1989;291-296
21. + hematopoietic progenitor cells. Blood. 87:1996;2632-2640
22. + human natural killer progenitor that responds to interleukin-15. Blood. 92:1998;3647-3657
23. Gilmour K.C., Fujii H., Cranston T., Davies E.G., Kinnon C., Gaspar H.B. Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. Blood. 98:2001;877-879
24. Cicuttini F.M., Martin M., Petrie H.T., Boyd A.W. A novel population of natural killer progenitor cells isolated from human umbilical cord blood. J Immunol. 151:1993;29-37
25. Phillips J.H., Hori T., Nagler A., Bhat N., Spits H., Lanier L.L. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J Exp Med. 175:1992;1055-1066
26. - cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol. 180:1997;132
27. Shibuya A., Nagaoshi K., Nakamura K., Nakauchi H. Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 85:1995;3538-3546
28. Silva M.R., Hoffman R., Srour E.F., Ascensao J.L. Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood. 84:1994;841-846
29. + immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur J Immunol. 26:1996;1266-1272
30. Warren H.S., Kinnear B.F., Skipsey L.J. Human natural killer (NK) cells: Requirements for cell proliferation and expansion of phenotypically novel subpopulations. Immunol Cell Biol. 71:1993;87-97
31. Robertson M.J., Cmeron C., Lazo S., Cochran K.J., Voss S.D., Ritz J. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Nat Immunol. 15:1996-97;213-226
32. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290:2000;84-89
33. Lanier L.L. On guard-activating NK cell receptors. Nat Immunol. 2:2001;23-27
34. Moretta A., Bottino C., Mingari M.C., Biassoni R., Moretta L. What is a natural killer cell? Nat Immunol. 3:2002;6-8